{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:58:10Z","timestamp":1780876690759,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SRM Institute of Science & Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48639-4","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:45:27Z","timestamp":1776289527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health-related quality of life in patients with psoriasis in Asian countries: a systematic review and meta-analysis of EQ-5D utility scores"],"prefix":"10.1038","volume":"16","author":[{"given":"Harshavardhan","family":"K","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyankaa","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"Murugadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Ayyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumitha","family":"Haridoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"48639_CR1","unstructured":"Get the Facts About. Psoriasis and Psoriatic Arthritis [Internet]. [cited 2025 Dec 7]. Available from: https:\/\/www.psoriasis.org\/psoriasis-statistics\/"},{"key":"48639_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1518681","author":"J Xiong","year":"2025","unstructured":"Xiong, J., Xue, T., Tong, M., Xu, L. & Bai, B. Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data. Front. Public. Health ;13:1518681. doi:https:\/\/doi.org\/10.3389\/fpubh.2025.1518681. (2025). PubMed PMID: 40703175; PubMed Central PMCID: PMC12283580."},{"issue":"1","key":"48639_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong, A. W. et al. Psoriasis Nat. Rev. Dis. Primer ;11(1):45. doi:https:\/\/doi.org\/10.1038\/s41572-025-00630-5 (2025).","journal-title":"Psoriasis Nat. Rev. Dis. Primer"},{"key":"48639_CR4","doi-asserted-by":"publisher","first-page":"743180","DOI":"10.3389\/fmed.2021.743180","volume":"8","author":"G Damiani","year":"2021","unstructured":"Damiani, G. et al. The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study. Front. Med. 8, 743180. https:\/\/doi.org\/10.3389\/fmed.2021.743180 (2021).","journal-title":"Front. Med."},{"key":"48639_CR5","doi-asserted-by":"publisher","unstructured":"Dairov, A., Issabekova, A., Sekenova, A., Shakhatbayev, M. & Ogay, V. Prevalence, incidence, gender and age distribution, and economic burden of psoriasis worldwide and in Kazakhstan. J. Clin. Med. Kaz. 21 (2). https:\/\/doi.org\/10.23950\/jcmk\/14497 (2024).","DOI":"10.23950\/jcmk\/14497"},{"issue":"3","key":"48639_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40259-014-0084-3","volume":"28","author":"F Spandonaro","year":"2014","unstructured":"Spandonaro, F. et al. The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. BioDrugs Clin. Immunother Biopharm. Gene Ther. 28 (3), 285\u2013295. https:\/\/doi.org\/10.1007\/s40259-014-0084-3 (2014). PubMed PMID: 24567261; PubMed Central PMCID: PMC4030097.","journal-title":"BioDrugs Clin. Immunother Biopharm. Gene Ther."},{"key":"48639_CR7","unstructured":"EQ-5D [Internet]. [cited 2025 Dec 7]. (2025). Available from: https:\/\/sheffield.ac.uk\/nice-dsu\/methods-development\/eq-5d"},{"issue":"7","key":"48639_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40273-016-0389-9","volume":"34","author":"M Karimi","year":"2016","unstructured":"Karimi, M. & Brazier, J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? PharmacoEconomics 34 (7), 645\u2013649. https:\/\/doi.org\/10.1007\/s40273-016-0389-9 (2016).","journal-title":"PharmacoEconomics"},{"issue":"4","key":"48639_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.dsi.2016.05.004","volume":"34","author":"WC Ko","year":"2016","unstructured":"Ko, W. C., Tsai, T. F. & Tang, C. H. Health state utility, willingness to pay, and quality of life among Taiwanese patients with psoriasis. Dermatol. Sin. 34 (4), 185\u2013191. https:\/\/doi.org\/10.1016\/j.dsi.2016.05.004 (2016).","journal-title":"Dermatol. Sin"},{"issue":"4","key":"48639_CR10","doi-asserted-by":"publisher","first-page":"e236802","DOI":"10.1001\/jamanetworkopen.2023.6802","volume":"6","author":"JM Gelfand","year":"2023","unstructured":"Gelfand, J. M. & Wang, S. Expanding the Global Perspective on Psoriasis. JAMA Netw. Open. 6 (4), e236802. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.6802 (2023).","journal-title":"JAMA Netw. Open."},{"key":"48639_CR11","doi-asserted-by":"crossref","unstructured":"Rayyan [Internet]. [cited 2025 Oct 23]. Available from: https:\/\/new.rayyan.ai\/","DOI":"10.5339\/jist.2025.15"},{"issue":"1","key":"48639_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"NJ Devlin","year":"2018","unstructured":"Devlin, N. J., Shah, K. K., Feng, Y., Mulhern, B. & Van Hout, B. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 27 (1), 7\u201322. https:\/\/doi.org\/10.1002\/hec.3564 (2018).","journal-title":"Health Econ."},{"key":"48639_CR13","doi-asserted-by":"crossref","unstructured":"Devlin, P. D. N., Roudijk, P. D. B., Ludwig, P. D. K. & Review, C. Glossary of EQ-5D Terms. In: Value Sets for EQ-5D-5L: A Compendium, & User Guide [Internet] [Internet]. Springer; [cited 2025 Nov 4]. (2022). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK589303\/","DOI":"10.1007\/978-3-030-89289-0"},{"key":"48639_CR14","doi-asserted-by":"publisher","unstructured":"Higgins, J. P. T. et al. (eds) Cochrane Handbook for Systematic Reviews of Interventions [Internet]. 1st ed. Wiley; [cited 2026 Apr 7]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/book\/ (2019). https:\/\/doi.org\/10.1002\/9781119536604 doi:10.1002\/9781119536604.","DOI":"10.1002\/9781119536604"},{"issue":"7109","key":"48639_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Smith, G. D., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (7109), 629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629 (1997).","journal-title":"BMJ"},{"issue":"4","key":"48639_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/1756-185X.13473","volume":"22","author":"P Chiowchanwisawakit","year":"2019","unstructured":"Chiowchanwisawakit, P., Srinonprasert, V., Thaweeratthakul, P. & Katchamart, W. Disease activity and functional status associated with health-related quality of life and patient-acceptable symptom state in patients with psoriatic arthritis in Thailand: A cross-sectional study. Int. J. Rheum. Dis. 22 (4), 700\u2013707. https:\/\/doi.org\/10.1111\/1756-185X.13473 (2019). Located at: rayyan-270380660.","journal-title":"Int. J. Rheum. Dis."},{"issue":"9","key":"48639_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.33192\/smj.v75i9.260756","volume":"75","author":"L Chularojanamontri","year":"2023","unstructured":"Chularojanamontri, L. et al. Evaluating Risk Factors for Cumulative Life Course Impairment in Psoriasis using Patient-Acceptable Symptom State and European Quality of Life 5 Dimensions (EQ-5D). Siriraj Med. J. 75 (9), 646\u2013654. https:\/\/doi.org\/10.33192\/smj.v75i9.260756 (2023). Located at.","journal-title":"Siriraj Med. J."},{"key":"48639_CR18","doi-asserted-by":"publisher","unstructured":"Sawangjit, R. et al. Health Utility and Its Relationship with Disease Activity and Physical Disability of Patients with Psoriatic Arthritis in Thailand. Nat Life Sci Commun. ;22(3). Located at: rayyan-270379257. (2023). https:\/\/doi.org\/10.12982\/NLSC.2023.040","DOI":"10.12982\/NLSC.2023.040"},{"issue":"3","key":"48639_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jdermsci.2021.01.002","volume":"101","author":"S Imafuku","year":"2021","unstructured":"Imafuku, S. et al. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study. J. Dermatol. Sci. 101 (3), 185\u2013193. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.01.002 (2021). Located at.","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"48639_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/1346-8138.13541","volume":"44","author":"S Masaki","year":"2017","unstructured":"Masaki, S. et al. Treatment satisfaction, willingness to pay and quality of life in Japanese patients with psoriasis. J. Dermatol. 44 (2), 143\u2013146. https:\/\/doi.org\/10.1111\/1346-8138.13541 (2017). Located at.","journal-title":"J. Dermatol."},{"issue":"10","key":"48639_CR21","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/jdv.16355","volume":"34","author":"T Yamamoto","year":"2020","unstructured":"Yamamoto, T. et al. Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis. J. Eur. Acad. Dermatol. Venereol. JEADV. 34 (10), 2318\u20132329. https:\/\/doi.org\/10.1111\/jdv.16355 (2020). Located at: rayyan-270380718.","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"5","key":"48639_CR22","first-page":"A159","volume":"20","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y. Does the choice of tariff matter? a comparison of EQ-5D-5l utility scores using China, UK and Japan tariffs on a psoriasis vulgaris sample in Mainland China. Value Health. 20 (5), A159 (2017). Located at: rayyan-270380107.","journal-title":"Value Health"},{"issue":"5","key":"48639_CR23","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11136-018-1819-2","volume":"27","author":"L Liu","year":"2018","unstructured":"Liu, L., Li, S., Zhao, Y., Zhang, J. & Chen, G. Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China. Qual. Life Res. Int. J. Qual. Life Asp Treat. Care Rehabil. 27 (5), 1323\u20131333. https:\/\/doi.org\/10.1007\/s11136-018-1819-2 (2018). Located at: rayyan-270380436.","journal-title":"Qual. Life Res. Int. J. Qual. Life Asp Treat. Care Rehabil"},{"issue":"7","key":"48639_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/13696998.2020.1748636","volume":"23","author":"J Su","year":"2020","unstructured":"Su, J., Liu, T., Li, S., Zhao, Y. & Kuang, Y. A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index. J. Med. Econ. 23 (7), 737\u2013743. https:\/\/doi.org\/10.1080\/13696998.2020.1748636 (2020). Located at.","journal-title":"J. Med. Econ."},{"issue":"4","key":"48639_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.dsi.2018.06.006","volume":"36","author":"TF Tsai","year":"2018","unstructured":"Tsai, T. F. et al. Health-related quality of life among patients with moderate-to-severe plaque psoriasis in Taiwan. Dermatol. Sin. 36 (4), 190\u2013195. https:\/\/doi.org\/10.1016\/j.dsi.2018.06.006 (2018). Located at.","journal-title":"Dermatol. Sin"},{"issue":"1","key":"48639_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/ijd.ijd_144_23","volume":"69","author":"K Arora","year":"2024","unstructured":"Arora, K., Hazarika, N., Kumari, R. & Chawla, H. Quality of Life in Psoriasis: A Cross-Sectional Study from North India. Indian J. Dermatol. 69 (1), 38\u201343. https:\/\/doi.org\/10.4103\/ijd.ijd_144_23 (2024). Located at: rayyan-270380966.","journal-title":"Indian J. Dermatol."},{"key":"48639_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jdin.2024.07.020","volume":"17","author":"YW Yew","year":"2024","unstructured":"Yew, Y. W., Barbieri, J. & Chen, S. C. Burden of chronic skin disease from an Asian perspective: Assessment of health state utilities and quality of life in a Singapore cohort. JAAD Int. 17, 86\u201393. https:\/\/doi.org\/10.1016\/j.jdin.2024.07.020 (2024). Located at.","journal-title":"JAAD Int."},{"issue":"2","key":"48639_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5021\/ad.22.041","volume":"35","author":"DH Kim","year":"2023","unstructured":"Kim, D. H. et al. Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study). Ann. Dermatol. 35 (2), 107\u2013115. https:\/\/doi.org\/10.5021\/ad.22.041 (2023). Located at: rayyan-270380824.","journal-title":"Ann. Dermatol."},{"issue":"6","key":"48639_CR29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3899\/jrheum.120782","volume":"40","author":"YY Leung","year":"2013","unstructured":"Leung, Y. Y., Png, M. E., Wee, H. L. & Thumboo, J. Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study. J. Rheumatol. 40 (6), 859\u2013865. https:\/\/doi.org\/10.3899\/jrheum.120782 (2013). Located at: rayyan-270380596.","journal-title":"J. Rheumatol."},{"issue":"6","key":"48639_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40273-020-00893-8","volume":"38","author":"AJ Thompson","year":"2020","unstructured":"Thompson, A. J. & Turner, A. J. A Comparison of the EQ-5D-3L and EQ-5D-5L. PharmacoEconomics 38 (6), 575\u2013591. https:\/\/doi.org\/10.1007\/s40273-020-00893-8 (2020).","journal-title":"PharmacoEconomics"},{"issue":"2","key":"48639_CR31","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1080\/09546634.2020.1800571","volume":"33","author":"Z Yang","year":"2022","unstructured":"Yang, Z., Li, S., Wang, X. & Chen, G. Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis. J. Dermatol. Treat. 33 (2), 1029\u20131036. https:\/\/doi.org\/10.1080\/09546634.2020.1800571 (2022).","journal-title":"J. Dermatol. Treat."},{"issue":"5","key":"48639_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1468-3083.2009.03463.x","volume":"24","author":"E Christophers","year":"2010","unstructured":"Christophers, E. et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J. Eur. Acad. Dermatol. Venereol. 24 (5), 548\u2013554. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03463.x (2010).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"48639_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/rheumatology\/ker365","volume":"51","author":"CF Rosen","year":"2012","unstructured":"Rosen, C. F. et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology 51 (3), 571\u2013576. https:\/\/doi.org\/10.1093\/rheumatology\/ker365 (2012).","journal-title":"Rheumatology"},{"key":"48639_CR34","doi-asserted-by":"publisher","unstructured":"M\u00f8ller, A., Karaoghlanian, N., Erntoft, S., Vinding, G. R. & Jemec, G. A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values. Patient Relat. Outcome Meas. 167 https:\/\/doi.org\/10.2147\/PROM.S81428 (2015).","DOI":"10.2147\/PROM.S81428"},{"issue":"3","key":"48639_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00403-012-1309-2","volume":"305","author":"C Blome","year":"2013","unstructured":"Blome, C., Beikert, F. C., Rustenbach, S. J. & Augustin, M. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities. Arch. Dermatol. Res. 305 (3), 197\u2013204. https:\/\/doi.org\/10.1007\/s00403-012-1309-2 (2013).","journal-title":"Arch. Dermatol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48639-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48639-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:04:49Z","timestamp":1780873489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48639-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48639"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48639-4","relation":{"references":[{"id-type":"doi","id":"10.3389\/fpubh.2025.1518681","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17593"}}